FDA should stand firm on stem-cell treatments – Nature.com
MinnPost |
FDA should stand firm on stem–cell treatments
Nature.com You may have heard that regulators in the United States are too strict when it comes to stem–cell treatments. If not, then you will probably hear that message soon — patient groups, entrepreneurs and politicians are broadcasting it as they lobby for a … Hundreds of US clinics promote unproven stem cell therapies, U of M researcher says 570 Clinics In The US Are Offering Expensive, Unproven And Unregulated Stem Cell Therapies And That's Very … Global Hematopoietic Stem Cell Transplantation Market Size, Share, Growth, Opportunities And Forecast to 2022 … |
